Ivaan Overseas

Genryzon (Somatrogon), is a medication for the treatment of growth hormone deficiency. Somatrogon is a glycosylated protein constructed from human growth hormone and a small part of human chorionic gonadotropin which is appended to both the N-terminal and C-terminal.

Genryzon (somatrogon) is a synthetic growth hormone that works by replacing the lack of growth hormone in the body. Genryzon is taken by injection just below the skin. Compared to the growth hormone GENOTROPIN^® (somatropin), its action in the body lasts longer, enabling weekly injections instead of daily. Genryzon is approved for the treatment of pediatric growth hormone deficiency (GHD) in Canada, Australia and Japan, and the EU marketing authorization is valid in all EU Member States as well as Iceland, Norway and Liechtenstein.

XTANE 25MG contain exemestane which belongs to a group of medicine called aromatase inhibitors. It is used to treat hormone dependent early breast cancer in postmenopausal women after they have completed 2-3 years of treatment with the medicine tamoxifen and hormone dependent advanced breast cancer in postmenopausal women when a different hormonal drugs treatment has not worked well enough.

3.75mg Luprodex Injection contains leuprolide acetate, a GnRH agonist used to manage hormone-dependent conditions such as prostate cancer, endometriosis, uterine fibroids, and precocious puberty by reducing sex hormone levels.